PTN
Palatin Technologies, Inc.
Price Chart
Latest Quote
$4.77
-0.05 (-1.04%)
Current Price
| Previous Close | $4.82 |
| Open | $4.93 |
| Day High | $5.02 |
| Day Low | $4.74 |
| Volume | 33,255 |
Stock Information
| Shares Outstanding | 1.78M |
| Total Debt | $224K |
| Cash Equivalents | $7.49M |
| Revenue | $13.19M |
| Net Income | $-8.38M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $8.50M |
| EPS (TTM) | $-2.96 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.23M |
| Sales | $13.19M |
| Income | $-8.38M |
| Book/sh | $3.76 |
| Cash/sh | $4.21 |
| Employees | 25 |
Financial Ratios
| Quick Ratio | 4.40 |
| Current Ratio | 4.61 |
| Debt/Eq | 3.35 |
Returns & Margins
| ROA | -91.90% |
| ROE | -877.53% |
| Gross Margin | 6.19% |
| Operating Margin | -1469.50% |
| Profit Margin | -63.54% |
Ownership
| Insider Ownership | 8.11% |
| Institutional Ownership | 50.11% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.57 |
| PEG | 1.62 |
| P/S | 0.64 |
| P/B | 1.27 |
Analyst Data
| Recommendation | none |
| Target Price | $53.50 |
Technical Indicators
| SMA20 | $7.36 |
| SMA50 | $9.46 |
| SMA200 | $14.21 |
| RSI | 0.62 |
| ATR | 0.8143 |
| Shares Float | 1.56M |
| Short Float | 25.00% |
| Short Ratio | 8.33 |
| Volatility | -0.01 |
| Rel Volume | 1.00 |
Performance History
| Week | -13.59% |
| Month | -50.21% |
| Quarter | -40.97% |
| 6 Months | -77.51% |
| YTD | -70.28% |
| Year | -20.50% |
| 3 Years | -96.03% |
| 5 Years | -99.09% |
| 10 Years | -99.24% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $4.77 | 33,300 |
| 2026-10-26 | $4.82 | 28,100 |
| 2026-10-23 | $5.11 | 126,600 |
| 2026-10-22 | $5.51 | 13,600 |
| 2026-10-21 | $5.55 | 20,500 |
| 2026-10-20 | $5.52 | 64,600 |
| 2026-10-19 | $5.99 | 56,400 |
| 2026-10-16 | $6.02 | 39,200 |
| 2026-10-15 | $6.49 | 43,400 |
| 2026-10-14 | $7.42 | 49,300 |
| 2026-10-13 | $8.19 | 14,200 |
| 2026-10-12 | $8.55 | 17,000 |
| 2026-10-09 | $8.60 | 31,400 |
| 2026-10-08 | $9.01 | 32,500 |
| 2026-10-07 | $9.52 | 9,000 |
| 2026-10-06 | $9.41 | 2,800 |
| 2026-10-05 | $9.48 | 13,000 |
| 2026-10-02 | $9.33 | 17,300 |
| 2026-10-01 | $9.06 | 33,000 |
| 2026-09-30 | $8.87 | 21,500 |
| 2026-09-29 | $9.12 | 32,800 |
| 2026-09-28 | $9.58 | 39,300 |
About Palatin Technologies, Inc.
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity completed Phase 2 clinical trial; completed a phase 2 of diabetic nephropathy It also provides pl9643 for dry eye disease; and oral PL8177 for inflammatory bowel diseases. licensing arrangements and other strategic transactions to advance and maximize the value of certain product candidates and program for the treatment of retinal diseases and with Altanispac Labs for PL9643 for the treatment of dry eye disease; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Princeton, New Jersey.
đ° Latest News
No news articles available at the moment. Check back later for updates on PTN.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $0 | $97,637 | $418,470 | $217,529 |
| Cost Of Revenue | $0 | $97,637 | $418,470 | $217,529 |
| Total Revenue | $0 | $4,490,090 | $4,853,678 | $1,468,457 |
| Operating Revenue | $0 | $8,875,153 | $12,463,140 | $6,066,530 |
| Expenses | ||||
| Interest Expense | $15,025 | $17,114 | $20,013 | $29,682 |
| Total Expenses | $22,707,839 | $34,768,055 | $38,339,883 | $38,056,905 |
| Other Income Expense | $5,415,515 | $558,966 | $4,794,478 | $419,831 |
| Net Non Operating Interest Income Expense | $-15,025 | $-17,114 | $-20,013 | $-29,682 |
| Interest Expense Non Operating | $15,025 | $17,114 | $20,013 | $29,682 |
| Operating Expense | $22,707,839 | $34,670,418 | $37,921,413 | $37,839,376 |
| Other Non Operating Income Expenses | - | $-696,912 | $-1,115,765 | - |
| Other Operating Expenses | - | - | $-1,027,322 | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Net Interest Income | $-15,025 | $-17,114 | $-20,013 | $-29,682 |
| Normalized Income | $-22,722,864 | $-30,991,991 | $-28,984,647 | $-36,618,130 |
| Net Income From Continuing And Discontinued Operation | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Total Operating Income As Reported | $-17,459,939 | $-22,496,121 | $-32,458,883 | $-36,588,448 |
| Net Income Common Stockholders | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Net Income | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Net Income Including Noncontrolling Interests | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Net Income Continuous Operations | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Pretax Income | $-17,307,349 | $-29,736,113 | $-28,711,740 | $-36,198,299 |
| Special Income Charges | $5,247,900 | $7,781,844 | $1,027,322 | $0 |
| Operating Income | $-22,707,839 | $-30,277,965 | $-33,486,205 | $-36,588,448 |
| Gross Profit | $0 | $4,392,453 | $4,435,208 | $1,250,928 |
| Per Share | ||||
| Diluted EPS | $-32.15 | $-101.16 | $-110.50 | $-189.50 |
| Basic EPS | $-32.15 | $-101.16 | $-110.50 | $-189.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $962,337 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-22,448,922 | $-30,635,802 | $-34,313,639 | $-36,461,780 |
| Total Unusual Items | $5,415,515 | $1,255,878 | $5,910,243 | $419,831 |
| Total Unusual Items Excluding Goodwill | $5,415,515 | $1,255,878 | $5,910,243 | $419,831 |
| Reconciled Depreciation | $258,917 | $339,075 | $288,331 | $126,668 |
| EBITDA (Bullshit earnings) | $-17,033,407 | $-29,379,924 | $-28,403,396 | $-36,041,949 |
| EBIT | $-17,292,324 | $-29,718,999 | $-28,691,727 | $-36,168,617 |
| Diluted Average Shares | $538,348 | $293,951 | $217,803 | $190,875 |
| Basic Average Shares | $538,348 | $293,951 | $217,803 | $190,875 |
| Diluted NI Availto Com Stockholders | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Gain On Sale Of Ppe | $3,130,000 | $7,781,844 | $0 | - |
| Other Special Charges | $-2,117,900 | - | $-1,027,322 | - |
| Gain On Sale Of Security | $167,615 | $-6,525,966 | $4,882,921 | $419,831 |
| Research And Development | $14,898,494 | $22,400,372 | $22,630,577 | $21,327,434 |
| Selling General And Administration | $7,809,345 | $12,270,046 | $15,290,836 | $16,511,942 |
| Tax Provision | - | $0 | $-4,674,999 | $0 |
Fetched: 2026-10-22
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-4,777,045 | $-111,497 | $-1,979,871 | $16,267,875 |
| Total Assets | $3,266,954 | $10,742,266 | $17,939,440 | $36,070,794 |
| Total Non Current Assets | $347,526 | $972,598 | $1,617,927 | $1,474,695 |
| Other Non Current Assets | $56,916 | $56,916 | $56,916 | $56,916 |
| Current Assets | $2,919,428 | $9,769,668 | $16,321,513 | $34,596,099 |
| Other Current Assets | $325,695 | $242,272 | $1,080,531 | $1,116,704 |
| Receivables | $29,468 | $0 | $2,915,760 | $1,780,020 |
| Other Receivables | $29,468 | - | - | - |
| Cash Cash Equivalents And Short Term Investments | $2,564,265 | $9,527,396 | $10,982,472 | $29,939,154 |
| Cash And Cash Equivalents | $2,564,265 | $9,527,396 | $7,989,582 | $29,939,154 |
| Cash Equivalents | $2,286,603 | $9,089,113 | $5,789,218 | $29,740,565 |
| Cash Financial | $277,662 | $438,283 | $2,200,364 | $198,589 |
| Prepaid Assets | - | $0 | $816,750 | $815,750 |
| Inventory | - | $0 | $526,000 | $944,471 |
| Accounts Receivable | - | $0 | $2,915,760 | $1,780,020 |
| Debt | ||||
| Total Debt | $163,781 | $590,338 | $1,050,781 | $1,153,850 |
| Long Term Debt And Capital Lease Obligation | $33,969 | $163,782 | $590,337 | $681,805 |
| Current Debt And Capital Lease Obligation | $129,812 | $426,556 | $460,444 | $472,045 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,043,999 | $10,853,763 | $19,919,311 | $19,802,919 |
| Total Non Current Liabilities Net Minority Interest | $33,969 | $1,196,082 | $4,787,481 | $3,543,055 |
| Current Liabilities | $8,010,030 | $9,657,681 | $15,131,830 | $16,259,864 |
| Payables And Accrued Expenses | $7,880,218 | $6,515,281 | $9,250,739 | $8,486,937 |
| Payables | $6,998,806 | $4,101,929 | $4,303,527 | $3,157,617 |
| Accounts Payable | $6,998,806 | $4,101,929 | $4,303,527 | $3,157,617 |
| Other Non Current Liabilities | - | $1,032,300 | $2,083,200 | $2,861,250 |
| Derivative Product Liabilities | - | $0 | $2,113,944 | - |
| Other Current Liabilities | - | $944,150 | $3,856,800 | $5,754,986 |
| Equity | ||||
| Common Stock Equity | $-4,777,119 | $-111,537 | $-1,979,911 | $16,267,835 |
| Preferred Stock Equity | $74 | $40 | $40 | $40 |
| Total Equity Gross Minority Interest | $-4,777,045 | $-111,497 | $-1,979,871 | $16,267,875 |
| Stockholders Equity | $-4,777,045 | $-111,497 | $-1,979,871 | $16,267,875 |
| Retained Earnings | $-459,073,899 | $-441,766,550 | $-412,030,437 | $-387,993,696 |
| Preferred Securities Outside Stock Equity | - | - | $0 | $0 |
| Other | ||||
| Ordinary Shares Number | $929,597 | $358,532 | $233,134 | $185,418 |
| Share Issued | $929,597 | $358,532 | $233,134 | $185,418 |
| Tangible Book Value | $-4,777,119 | $-111,537 | $-1,979,911 | $16,267,835 |
| Invested Capital | $-4,777,119 | $-111,537 | $-1,979,911 | $16,267,835 |
| Working Capital | $-5,090,602 | $111,987 | $1,189,683 | $18,336,235 |
| Capital Lease Obligations | $163,781 | $590,338 | $1,050,781 | $1,153,850 |
| Total Capitalization | $-4,777,045 | $-111,497 | $-1,979,871 | $16,267,875 |
| Additional Paid In Capital | $454,287,484 | $441,651,428 | $409,933,959 | $404,168,822 |
| Capital Stock | $9,370 | $3,625 | $116,607 | $92,749 |
| Common Stock | $9,296 | $3,585 | $116,567 | $92,709 |
| Preferred Stock | $74 | $40 | $40 | $40 |
| Long Term Capital Lease Obligation | $33,969 | $163,782 | $590,337 | $681,805 |
| Current Capital Lease Obligation | $129,812 | $426,556 | $460,444 | $472,045 |
| Pensionand Other Post Retirement Benefit Plans Current | $0 | $1,771,694 | $1,563,847 | $1,545,896 |
| Current Accrued Expenses | $881,412 | $2,413,352 | $4,947,212 | $5,329,320 |
| Net PPE | $290,610 | $915,682 | $1,561,011 | $1,417,779 |
| Accumulated Depreciation | $-3,516,957 | $-3,258,040 | $-2,918,964 | $-2,630,634 |
| Gross PPE | $3,807,567 | $4,173,722 | $4,479,975 | $4,048,413 |
| Leases | $1,196,706 | $1,196,706 | $1,196,706 | $902,038 |
| Other Properties | $1,220,395 | $1,220,395 | $1,177,868 | $1,038,610 |
| Machinery Furniture Equipment | $1,229,300 | $1,229,300 | $1,229,300 | $1,229,300 |
| Buildings And Improvements | $161,166 | $527,321 | $876,101 | $878,465 |
| Properties | $0 | $0 | $0 | $0 |
| Preferred Shares Number | - | $4,030 | $4,030 | $4,030 |
| Finished Goods | - | $0 | $0 | $418,471 |
| Raw Materials | - | $0 | $526,000 | $526,000 |
| Other Short Term Investments | - | $0 | $2,992,890 | $0 |
Fetched: 2026-10-22
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-21,306,637 | $-31,503,967 | $-29,705,273 | $-30,184,123 |
| Operating Activities | ||||
| Operating Cash Flow | $-21,306,637 | $-31,461,441 | $-29,271,346 | $-29,922,749 |
| Cash Flow From Continuing Operating Activities | $-21,306,637 | $-31,461,441 | $-29,271,346 | $-29,922,749 |
| Operating Gains Losses | $-3,129,950 | $-879,035 | $-4,190,940 | $-155,425 |
| Investing Activities | ||||
| Investing Cash Flow | $3,130,000 | $12,450,364 | $-3,426,817 | $-261,374 |
| Cash Flow From Continuing Investing Activities | $3,130,000 | $12,450,364 | $-3,426,817 | $-261,374 |
| Capital Expenditure | - | $-42,526 | $-433,927 | $-261,374 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $7,960,765 | $14,666,042 | $10,995,497 | $0 |
| Financing Cash Flow | $11,213,506 | $20,548,891 | $10,748,591 | $18,358 |
| Cash Flow From Continuing Financing Activities | $11,213,506 | $20,548,891 | $10,748,591 | $18,358 |
| Net Other Financing Charges | $-99,482 | $-56,401 | $-146,062 | $-221,311 |
| Net Common Stock Issuance | $7,960,765 | $14,666,042 | $10,995,497 | $0 |
| Common Stock Issuance | $7,960,765 | $14,666,042 | $10,995,497 | $0 |
| Other | ||||
| Repayment Of Debt | $-46,014 | $-106,392 | $-100,922 | $-56,463 |
| Interest Paid Supplemental Data | $15,025 | $17,114 | $20,013 | $29,682 |
| End Cash Position | $2,564,265 | $9,527,396 | $7,989,582 | $29,939,154 |
| Beginning Cash Position | $9,527,396 | $7,989,582 | $29,939,154 | $60,104,919 |
| Changes In Cash | $-6,963,131 | $1,537,814 | $-21,949,572 | $-30,165,765 |
| Proceeds From Stock Option Exercised | $3,398,237 | $6,045,642 | $78 | $296,132 |
| Net Issuance Payments Of Debt | $-46,014 | $-106,392 | $-100,922 | $-56,463 |
| Net Long Term Debt Issuance | $-46,014 | $-106,392 | $-100,922 | $-56,463 |
| Long Term Debt Payments | $-46,014 | $-106,392 | $-100,922 | $-56,463 |
| Net Investment Purchase And Sale | $0 | $2,992,890 | $-2,992,890 | $0 |
| Sale Of Investment | $0 | $2,992,890 | $0 | - |
| Net Intangibles Purchase And Sale | $3,130,000 | $9,500,000 | $0 | - |
| Sale Of Intangibles | $3,130,000 | $9,500,000 | $0 | - |
| Net PPE Purchase And Sale | $0 | $-42,526 | $-433,927 | $-261,374 |
| Purchase Of PPE | $0 | $-42,526 | $-433,927 | $-261,374 |
| Change In Working Capital | $-758,791 | $-3,406,846 | $-2,350,350 | $3,439,421 |
| Change In Other Current Liabilities | $-239,143 | $-3,817,848 | $-2,413,638 | $-1,356,251 |
| Change In Payables And Accrued Expense | $-406,757 | $-2,569,249 | $745,384 | $3,650,495 |
| Change In Accrued Expense | $-3,303,634 | $-2,367,651 | $-364,157 | $1,077,838 |
| Change In Payable | $2,896,877 | $-201,598 | $1,109,541 | $2,572,657 |
| Change In Account Payable | $2,896,877 | $-201,598 | $1,109,541 | $2,572,657 |
| Change In Prepaid Assets | $-83,423 | $1,218,846 | $35,173 | $1,127,225 |
| Change In Inventory | $0 | $-1,154,355 | $418,471 | $217,529 |
| Change In Receivables | $-29,468 | $2,915,760 | $-1,135,740 | $-199,577 |
| Changes In Account Receivables | $0 | $2,915,760 | $-1,135,740 | $-199,577 |
| Other Non Cash Items | $-1,751,745 | $348,780 | $-655,983 | $359,348 |
| Stock Based Compensation | $1,382,281 | $1,872,698 | $1,674,337 | $2,505,538 |
| Depreciation Amortization Depletion | $258,917 | $339,075 | $288,331 | $126,668 |
| Depreciation And Amortization | $258,917 | $339,075 | $288,331 | $126,668 |
| Net Foreign Currency Exchange Gain Loss | $50 | $-59,753 | $429,971 | $-389,868 |
| Gain Loss On Sale Of PPE | $-3,130,000 | $-7,781,844 | $0 | - |
| Net Income From Continuing Operations | $-17,307,349 | $-29,736,113 | $-24,036,741 | $-36,198,299 |
| Gain Loss On Investment Securities | - | $6,962,562 | $-4,620,911 | $234,443 |
| Purchase Of Investment | - | - | $-2,992,890 | $0 |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
| Change In Other Current Assets | - | - | - | - |
Fetched: 2026-10-22